NuGene_news

Lanque Bio（Rnacure) signed a contract with Shanghai Baoshan District to build an mRNA clinical drug R&D and production base

Product / By

Recently, Baoshan District, Shanghai, signed a contract with Lanque Biotechnology(Rnacure) to build an mRNA clinical drug R&D and GMP production base . Lanque Biology will plan and build a 5000 square meter R&D center and a 10,000 square meter GMP production base in Songnan Town and Luodian Town respectively, forming a spatial layout of “Southern …

Lanque Bio（Rnacure) signed a contract with Shanghai Baoshan District to build an mRNA clinical drug R&D and production base Read More »

The Lancet published the Phase III clinical trial results on the safety and efficacy of “Ad5-nCoV”

China, News, R&D / By

Dec 23, 2021，CanSino Biologics Inc. announced that The Lancet published its Phase III clinical trial results on the safety and efficacy of its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (“Ad5-nCoV”, trade name: Convidecia™). The publication of the analysis showed that a single dose of Convidecia™ is efficacious and safe with an efficacy of 96.0% in preventing …

The Lancet published the Phase III clinical trial results on the safety and efficacy of “Ad5-nCoV” Read More »